MARRI, SILVIA Statistiche
MARRI, SILVIA
DIPARTIMENTO DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA
From Antigenic Drive to Clonal Autonomy: An Update on Molecular Mechanisms of HCV-Related B-Cell Lymphomagenesis
2026-01-01 Marri, Silvia; Scavuzzo, Maria Concetta; Cavallini, Gabriella; Gragnani, Laura
HCV-related cryoglobulinemic vasculitis (mixed cryoglobulinemia syndrome) in the era of direct-acting antivirals: A 10-year experience from Italian tertiary referral centers
2026-01-01 Ferri, Clodoveo; Visentini, Marcella; Vacchi, Caterina; Lauletta, Gianfranco; Naclerio, Caterina; De Giorgi, Irene; Caruso, Teresita; Villa, Annalisa; D'Ambrosi, Matteo; D'Arcangelo, Francesca; Marri, Silvia; Fallahi, Poupak; Antonelli, Alessandro; Zignego, Anna Linda; Giuggioli, Dilia; Gragnani, Laura; Casato, Milvia
The Role of Direct-Acting Antivirals (DAAs) in Hepatitis C Virus-Associated Lymphoproliferative Disorders
2026-01-01 Mazzaro, Cesare; Bomben, Riccardo; Gragnani, Laura; Visentini, Marcella; Agostinis, Paolo; Marri, Silvia; Zignego, Anna Linda; Gattei, Valter
Outcomes of HBV and HCV testing in Italy’s marginalized communities: a step towards WHO plan to end viral hepatitis as a public health threat by 2030
2025-01-01 De Giorgi, I.; Monti, M.; Caruso, T.; Castellaccio, A.; Cavallini, G.; Manca, M. L.; Lorini, S.; Marri, S.; Petraccia, L.; Madia, F.; Stasi, C.; Carraresi, L.; Lorefice, E.; Bonelli, S. I.; Nerli, A.; Martini, L.; Gitto, S.; Aquilini, D.; Blanc, P.; Zignego, A. L.; Gragnani, L.
SC22 HBV and HCV testing in Italy’s marginalized groups: advancing who’s 2030 elimination goal
2025-01-01 Caruso, T; De Giorgi, I; Monti, M; Castellaccio, A; Cavallini, G; Manca, Ml; Lorini, S; Marri, S; Petraccia, L; Madia, F; Stasi, C; Carraresi, L; Lorefice, E; Bonelli, Si; Nerli, A; Martini, L; Gitto, S; Aquilini, D; Blanc, P; Zignego, Al; Gragnani, L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| From Antigenic Drive to Clonal Autonomy: An Update on Molecular Mechanisms of HCV-Related B-Cell Lymphomagenesis | 1-gen-2026 | Marri, Silvia; Scavuzzo, Maria Concetta; Cavallini, Gabriella; Gragnani, Laura | |
| HCV-related cryoglobulinemic vasculitis (mixed cryoglobulinemia syndrome) in the era of direct-acting antivirals: A 10-year experience from Italian tertiary referral centers | 1-gen-2026 | Ferri, Clodoveo; Visentini, Marcella; Vacchi, Caterina; Lauletta, Gianfranco; Naclerio, Caterina; De Giorgi, Irene; Caruso, Teresita; Villa, Annalisa; D'Ambrosi, Matteo; D'Arcangelo, Francesca; Marri, Silvia; Fallahi, Poupak; Antonelli, Alessandro; Zignego, Anna Linda; Giuggioli, Dilia; Gragnani, Laura; Casato, Milvia | |
| The Role of Direct-Acting Antivirals (DAAs) in Hepatitis C Virus-Associated Lymphoproliferative Disorders | 1-gen-2026 | Mazzaro, Cesare; Bomben, Riccardo; Gragnani, Laura; Visentini, Marcella; Agostinis, Paolo; Marri, Silvia; Zignego, Anna Linda; Gattei, Valter | |
| Outcomes of HBV and HCV testing in Italy’s marginalized communities: a step towards WHO plan to end viral hepatitis as a public health threat by 2030 | 1-gen-2025 | De Giorgi, I.; Monti, M.; Caruso, T.; Castellaccio, A.; Cavallini, G.; Manca, M. L.; Lorini, S.; Marri, S.; Petraccia, L.; Madia, F.; Stasi, C.; Carraresi, L.; Lorefice, E.; Bonelli, S. I.; Nerli, A.; Martini, L.; Gitto, S.; Aquilini, D.; Blanc, P.; Zignego, A. L.; Gragnani, L. | |
| SC22 HBV and HCV testing in Italy’s marginalized groups: advancing who’s 2030 elimination goal | 1-gen-2025 | Caruso, T; De Giorgi, I; Monti, M; Castellaccio, A; Cavallini, G; Manca, Ml; Lorini, S; Marri, S; Petraccia, L; Madia, F; Stasi, C; Carraresi, L; Lorefice, E; Bonelli, Si; Nerli, A; Martini, L; Gitto, S; Aquilini, D; Blanc, P; Zignego, Al; Gragnani, L |